Companies/AegirBio AB
Follow

AegirBio AB

Nasdaq First North GM Stockholm (Sweden)

AegirBio is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.
Go to market

Sector:
HEALTH CARE
>
Medical Instruments & Supplies
Healthcare
Media
Showing 3 of 6
View all
www.aegirbio.com
Current instruments
Type
Ticker
ISIN
SHARE
AEGIR
SE0014401121
Nasdaq First North GM Stockholm Sweden (SE)
OPTION
AEGIR TO2
SE0018012379
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
AEGIR
SE0014401121
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in AegirBio AB with ticker AEGIR
Status
Active
Amount of instruments
16 834 062
Currency
SEK
First trading date
26 Jun 2020
Exercise
Sign in to buy
Non-cash issue
Sign in to buy
Non-cash issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
AEGIR TO2
SE0018012379
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in AegirBio AB with ticker AEGIR TO2
Status
Active
Amount of instruments
1 979 893
Currency
SEK
Trading period
20 Jul 2022 - 01 Dec 2022
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period of ten (10) trading days before the first day of subscription, however, not less than share quota value and not more than SEK 20.40 per share.
Update (14.07.2022): First trading day for warrants TO2 is July 20, 2022.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
AEGIR
SE0014401121
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in AegirBio AB with ticker AEGIR
Status
Active
Amount of instruments
16 834 062
Currency
SEK
First trading date
26 Jun 2020
Non-cash issue
Sign in to buy
Non-cash issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
AEGIR TO1
SE0014428926
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in AegirBio AB with ticker AEGIR TO1
Status
Archived
Amount of instruments
2 460 000
Currency
SEK
Trading period
26 Jun 2020 - 24 Mar 2021
Terms
One (1) warrant of series TO1 gives the right to subscribe for one (1) new share in the Company.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
AEGIR TO2
SE0018012379
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in AegirBio AB with ticker AEGIR TO2
Status
Active
Amount of instruments
1 979 893
Currency
SEK
Trading period
20 Jul 2022 - 01 Dec 2022
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period of ten (10) trading days before the first day of subscription, however, not less than share quota value and not more than SEK 20.40 per share.
Update (14.07.2022): First trading day for warrants TO2 is July 20, 2022.
Exercise
Sign in to buy
People
Bradley Messmer
CEO
Anders Ingvarsson
Chairman of the board
Fredrik Häglund
Board member
Seppo Mäkinen
Board member
Bradley Messmer
Board member
Patrik Elfwing
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Sölvegatan 43 A
Zip code
223 70
City/district
Lund
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
559222-2953
LEI code
549300MWGS283WZLYI10
First trade date
26 Jun 2020
Registration date
14 Oct 2019
Short name
AEGIR

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More